QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 00:27 UTC · Public disclosure record

AIQUYTICKER

Air Liquide Adr France

NEUTRAL stock

Congress has disclosed 6 buys and 11 sells of AIQUY (Air Liquide Adr France) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

6
Buy
11
Sell
-5
Net
6
Active politicians

Round-trip watch Still on the books

Members who disclosed buying AIQUY and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Alan Armstrong 2026-03-31 $40.71 $40.37 -0.8% ↩ near entry

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

17 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Alan Armstrong Senate BUY Self 2026-03-31 112 days -1.2% $1K–$15K 49.3 ↗ eFD
Alan Armstrong Senate BUY Self 2026-03-30 113 days +1.6% $15K–$50K 92.5 ↗ eFD
Josh Gottheimer House SELL Joint · Morgan Stanley - Select UMA Account # 1 2024-06-21 17 days — $1K–$15K
<0.1% of NW
1.0 ↗ filing
Daniel Goldman House SELL Self · Daniel Goldman Grandchildren 1986 Trust > TLH ADR 2023-07-10 25 days — $15K–$50K
<0.1% of NW
90.9 ↗ filing
Peter Meijer House SELL Self 2021-02-17 2 days — $1K–$15K 75.9 ↗ filing
Greg Gianforte House BUY Joint 2020-08-05 5 days — $15K–$50K 30.7 ↗ filing
Greg Gianforte House SELL Joint 2020-01-13 8 days — $15K–$50K 48.0 ↗ filing
Donna Shalala House SELL Self 2019-06-24 6 days — $1K–$15K 22.3 ↗ filing
Josh Gottheimer House SELL Joint 2019-03-19 16 days — $1K–$15K
<0.1% of NW
19.6 ↗ filing
Donna Shalala House SELL Self 2019-03-19 12 days — $1K–$15K 52.4 ↗ filing
Josh Gottheimer House SELL Joint 2019-03-18 17 days — $1K–$15K
<0.1% of NW
26.5 ↗ filing
Donna Shalala House SELL Self 2019-03-18 13 days — $1K–$15K 86.8 ↗ filing
Greg Gianforte House SELL Joint 2018-12-07 3 days — $100K–$250K 84.5 ↗ filing
Josh Gottheimer House SELL Joint 2018-11-29 12 days — $1K–$15K
<0.1% of NW
31.8 ↗ filing
Greg Gianforte House BUY Joint 2017-09-27 5 days — $100K–$250K 97.8 ↗ filing
Josh Gottheimer House BUY Joint 2017-09-22 320 days — $1K–$15K
<0.1% of NW
52.4 ↗ filing
Josh Gottheimer House BUY Joint 2017-09-21 321 days — $1K–$15K
<0.1% of NW
86.8 ↗ filing

FAQ Common questions

How much has Congress traded AIQUY?

6 disclosed buys and 11 sells of AIQUY (Air Liquide Adr France) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade AIQUY?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.